| 2007 JASN IMPACT FACTOR 7.111 | HOME AUTHOR INFO EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP | |||
| CURRENT ISSUE | ARCHIVES | JASN Express | ONLINE SUBMISSION | |
REVIEW |
Department of Laboratory Medicine & Pathobiology, University of Toronto, Toronto, Ontario, and Department of Medicine, University of British Columbia, Koerner Pavilion, University Hospital, Vancouver, British Columbia, Canada.
Correspondence to Dr. Gary A. Quamme, Department of Medicine, University Hospital, Koerner Pavilion, 2211 Wesbrook Mall, Vancouver, BC, Canada V6T 1Z3. Phone: 604-822-7156; Fax: 604-822-7897; E-mail: quamme{at}interchange.ubc.ca
Abstract. The genetic basis and cellular defects of a number of primary magnesium wasting diseases have been elucidated over the past decade. This review correlates the clinical pathophysiology with the primary defect and secondary changes in cellular electrolyte transport. The described disorders include (1) hypomagnesemia with secondary hypocalcemia, an earlyonset, autosomal-recessive disease segregating with chromosome 9q12-22.2; (2) autosomal-dominant hypomagnesemia caused by isolated renal magnesium wasting, mapped to chromosome 11q23; (3) hypomagnesemia with hypercalciuria and nephrocalcinosis, a recessive condition caused by a mutation of the claudin 16 gene (3q27) coding for a tight junctional protein that regulates paracellular Mg2+ transport in the loop of Henle; (4) autosomal-dominant hypoparathyroidism, a variably hypomagnesemic disorder caused by inactivating mutations of the extracellular Ca2+/Mg2+-sensing receptor, Casr gene, at 3q13.3-21 (a significant association between common polymorphisms of the Casr and extracellular Mg2+ concentration has been demonstrated in a healthy adult population); and (5) Gitelman syndrome, a recessive form of hypomagnesemia caused by mutations in the distal tubular NaCl cotransporter gene, SLC12A3, at 16q13. The basis for renal magnesium wasting in this disease is not known. These inherited conditions affect different nephron segments and different cell types and lead to variable but increasingly distinguishable phenotypic presentations. No doubt, there are in the general population other disorders that have not yet been identified or characterized. The continued use of molecular techniques to probe the constitutive and congenital disturbances of magnesium metabolism will increase the understanding of cellular magnesium transport and provide new insights into the way these diseases are diagnosed and managed.
This article has been cited by other articles:
![]() |
L. J. Rondon, W. M. T. Groenestege, Y. Rayssiguier, and A. Mazur Relationship between low magnesium status and TRPM6 expression in the kidney and large intestine Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2008; 294(6): R2001 - R2007. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G. J. Hoenderop and R. J. M. Bindels Calciotropic and Magnesiotropic TRP Channels Physiology, February 1, 2008; 23(1): 32 - 40. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. M. Tong and R. K. Rude Magnesium Deficiency in Critical Illness J Intensive Care Med, January 1, 2005; 20(1): 3 - 17. [Abstract] [PDF] |
||||
![]() |
J. G.J. Hoenderop and R. J.M. Bindels Epithelial Ca2+ and Mg2+ Channels in Health and Disease J. Am. Soc. Nephrol., January 1, 2005; 16(1): 15 - 26. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Konrad, K. P. Schlingmann, and T. Gudermann Insights into the molecular nature of magnesium homeostasis Am J Physiol Renal Physiol, April 1, 2004; 286(4): F599 - F605. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Zelikovic Hypokalaemic salt-losing tubulopathies: an evolving story Nephrol. Dial. Transplant., September 1, 2003; 18(9): 1696 - 1700. [Full Text] [PDF] |
||||
![]() |
M. Konrad and S. Weber Recent Advances in Molecular Genetics of Hereditary Magnesium-Losing Disorders J. Am. Soc. Nephrol., January 1, 2003; 14(1): 249 - 260. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Mayan, I. Vered, M. Mouallem, M. Tzadok-Witkon, R. Pauzner, and Z. Farfel Pseudohypoaldosteronism Type II: Marked Sensitivity to Thiazides, Hypercalciuria, Normomagnesemia, and Low Bone Mineral Density J. Clin. Endocrinol. Metab., July 1, 2002; 87(7): 3248 - 3254. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Kantorovich, J. S. Adams, J. E. Gaines, X. Guo, M. R. Pandian, D. H. Cohn, and R. K. Rude* Genetic Heterogeneity in Familial Renal Magnesium Wasting J. Clin. Endocrinol. Metab., February 1, 2002; 87(2): 612 - 617. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. WEBER, L. SCHNEIDER, M. PETERS, J. MISSELWITZ, G. RONNEFARTH, M. BOSWALD, K. E. BONZEL, T. SEEMAN, T. SULAKOVA, E. KUWERTZ-BROKING, et al. Novel Paracellin-1 Mutations in 25 Families with Familial Hypomagnesemia with Hypercalciuria and Nephrocalcinosis J. Am. Soc. Nephrol., September 1, 2001; 12(9): 1872 - 1881. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. K. Wetzel and K. J. Sweadner Immunocytochemical localization of Na-K-ATPase alpha - and gamma -subunits in rat kidney Am J Physiol Renal Physiol, September 1, 2001; 281(3): F531 - F545. [Abstract] [Full Text] [PDF] |
||||
|
HOME
CURRENT ISSUE
ARCHIVES
JASN Express
ONLINE SUBMISSION
AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP |
Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673